trending Market Intelligence /marketintelligence/en/news-insights/trending/jqvicrvg1qf3qvlktnobha2 content esgSubNav
In This List

Albireo Pharma chief corporate officer to step down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Albireo Pharma chief corporate officer to step down

Peter Zorn stepped down from his positions as chief corporate officer, general counsel and secretary of Albireo Pharma Inc. to pursue other opportunities.

Zorn's departure is effective April 1.